X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
48-h acid reflux monitoring (1) 1
48‐h acid reflux monitoring (1) 1
acg guidelines (1) 1
acid suppression (1) 1
aihc (1) 1
american industrial health council, usa (1) 1
animals (1) 1
api-023 (1) 1
api‐023 (1) 1
aspect trial (1) 1
baclofen (1) 1
barrett esophagus - drug therapy (1) 1
barrett esophagus; drug therapy, chemoprevention, humans, monitoring; physiologic, proton pump inhibitors; therapeutic use, treatment outcome (1) 1
barrett's esophagus (1) 1
bile acids (1) 1
bilitec probe (1) 1
bioassay, carcinogenicity (1) 1
biological assay (1) 1
body-mass index (1) 1
body-weight (1) 1
cancer (1) 1
carcinogenicity bioassay (1) 1
carcinogenicity tests (1) 1
carcinoids (1) 1
cefic (1) 1
cell hyperplasia (1) 1
chemical manufacturers association, usa (1) 1
chemoprevention (1) 1
clostridium difficile (1) 1
cma (1) 1
cma omeprazole (1) 1
competitive acid blocker (1) 1
cox-2 inhibitors (1) 1
cox‐2 inhibitors (1) 1
data interpretation, statistical (1) 1
deoxycholic acid (1) 1
dexlansoprazole (1) 1
dexlansoprazole mr (1) 1
digestive system diseases (1) 1
drug administration routes (1) 1
drugs (1) 1
ecetoc (1) 1
erosive esophigitis (1) 1
esophagus (1) 1
european chemical industry ecology & toxicology centre, belgium (1) 1
european council of chemical manufacturers federations, belgium (1) 1
functional dyspepsia (1) 1
functional heartburn (1) 1
fundic glands polyp (1) 1
gaba (1) 1
gaba agonist baclofen (1) 1
gabab (1) 1
gastroenterology & hepatology (1) 1
gastroesophageal reflux (1) 1
gastroesophageal-reflux disease (1) 1
gastrointestinal diseases (1) 1
gerd (1) 1
growth (1) 1
healthy-volunteers (1) 1
humans (1) 1
iarc (1) 1
ifstp (1) 1
ilaprazole (1) 1
immediate-release omeprazole (1) 1
index medicus (1) 1
inhibitors (1) 1
international agency for research on cancer, france (1) 1
international federation of societies of toxicologic pathologists (1) 1
medical colleges (1) 1
mice (1) 1
monitoring (1) 1
monitoring, physiologic (1) 1
multichannel intraluminal impedance (1) 1
multidisciplinary sciences (1) 1
national cancer advisory board, usa (1) 1
national toxicology program, usa (1) 1
ncab (1) 1
nerd (1) 1
nocturnal acid breakthrough (1) 1
nonsteroidal anti-inflammatory drugs (1) 1
ntp (1) 1
obesity (1) 1
oecd (1) 1
omeprazole (1) 1
organisation for economic cooperation and development, france (1) 1
period (1) 1
ph testing (1) 1
pharmaceutical manufacturers association, usa (1) 1
pharmacokinetic changes (1) 1
pma (1) 1
ppi therapy (1) 1
prevention (1) 1
prokinetic agents (1) 1
proton pump inhibitors - therapeutic use (1) 1
pumps (1) 1
rabeprazole (1) 1
rats (1) 1
research design (1) 1
rodent carcinogenicity bioassay (1) 1
segments (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of the New York Academy of Sciences, ISSN 0077-8923, 09/2011, Volume 1232, Issue 1, pp. 114 - 139
The following on proton pump inhibitors (PPIs) and chemoprevention in relation to Barrett's esophagus includes commentaries on 48‐h pH monitoring,... 
functional heartburn | CMA omeprazole | erosive esophigitis | API‐023 | functional dyspepsia | tenatoprazole | NERD | ilaprazole | ACG guidelines | GABAB | Symptom Association Probability | bile acids | AspECT trial | Barrett's esophagus | rabeprazole | Bilitec probe | 48‐h acid reflux monitoring | Clostridium difficile | COX‐2 inhibitors | baclofen | TLESR | STU‐Na | PPI therapy | GERD | fundic glands polyp | nocturnal acid breakthrough | dexlansoprazole | pH testing | acid suppression | pharmacokinetic changes | COX-2 inhibitors | STU-Na | Pharmacokinetic changes | Tenatoprazole | Rabeprazole | API-023 | Fundic glands polyp | Nocturnal acid breakthrough | Baclofen | Functional heartburn | Acid suppression | Dexlansoprazole | Bile acids | PH testing | 48-h acid reflux monitoring | Functional dyspepsia | Erosive esophigitis | Ilaprazole | COMPETITIVE ACID BLOCKER | IMMEDIATE-RELEASE OMEPRAZOLE | SPHINCTER RELAXATIONS | GABA(B) | GASTROESOPHAGEAL-REFLUX DISEASE | DEXLANSOPRAZOLE MR | GABA(B) AGONIST BACLOFEN | MULTIDISCIPLINARY SCIENCES | MULTICHANNEL INTRALUMINAL IMPEDANCE | BODY-MASS INDEX | HEALTHY-VOLUNTEERS | GASTROENTEROLOGY & HEPATOLOGY | Treatment Outcome | Monitoring, Physiologic | Proton Pump Inhibitors - therapeutic use | Barrett Esophagus - drug therapy | Chemoprevention | Humans | Gastroesophageal reflux | Medical colleges | Prokinetic agents | Deoxycholic acid | Prevention | Omeprazole | Gastrointestinal diseases | GABA | Cancer | Side effects | Nonsteroidal anti-inflammatory drugs | Drugs | Obesity | Inhibitors | Pumps | Segments | Monitoring | Esophagus
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.